Bryant, AR5 Active Studies

Atopic Dermatitis Clinical Trials in Bryant, AR

Find 5 actively recruiting atopic dermatitis clinical trials in Bryant, AR. Connect with local research sites and explore new treatment options.

5
Active Trials
5
Sponsors
4,577
Enrolling

Recruiting Atopic Dermatitis Studies in Bryant

RecruitingBryant, ARNCT05882877

A Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)

The primary objective of this study is to describe the long-term safety and tolerability of rocatinlimab in participants with moderate-to-severe AD....

2,200 participants
Amgen
View Study Details
RecruitingBryant, ARNCT06468228

A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa

Hidradenitis suppurativa (HS) is a chronic and often painful inflammatory skin disease which includes the forming of lumps, abscesses and scars in areas of the skin such as under the breasts, under ar...

1,280 participants
AbbVie
View Study Details
RecruitingBryant, ARNCT05769777

Open Label, Long-term Study Evaluating Safety and Efficacy of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis

This is a single group, 1-arm, long-term safety study for treatment of participants with moderate to severe atopic dermatitis (AD). The purpose of this study is to characterize the long-term safety a...

901 participants
Sanofi
View Study Details
RecruitingBryant, ARNCT06998056

Safety Study of Roflumilast Cream 0.05% in Infants Aged 3 Months to Less Than 2 Years With Atopic Dermatitis

This study will assess the safety and tolerability of ARQ-151 cream 0.05% applied once a day for 4 weeks in infants with atopic dermatitis (eczema)....

100 participants
Arcutis Biotherapeutics, Inc.
View Study Details
RecruitingBryant, ARNCT07011706

ATI-045 Versus Placebo in Patients With Moderate-to-Severe Atopic Dermatitis

This study evaluates ATI-045 versus placebo in patients with Moderate-to-Severe Atopic Dermatitis....

96 participants
Aclaris Therapeutics, Inc.
View Study Details

About Atopic Dermatitis Clinical Trials in Bryant

Atopic dermatitis (eczema) is a chronic inflammatory skin condition causing itchy, red, and dry skin. It is the most common form of eczema, often beginning in childhood. Treatment includes moisturizers, topical corticosteroids, immunomodulators, and newer biologics like dupilumab.

There are currently 5 atopic dermatitis clinical trials recruiting participants in Bryant, AR. These studies are seeking a combined 4,577 participants. Research is being sponsored by Amgen, AbbVie, Sanofi and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Atopic Dermatitis Clinical Trials in Bryant — FAQ

Are there atopic dermatitis clinical trials in Bryant?

Yes, there are 5 atopic dermatitis clinical trials currently recruiting in Bryant, AR. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Bryant?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Bryant research site will contact you about next steps.

Are clinical trials in Bryant free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Bryant studies also compensate for your time and travel.

What atopic dermatitis treatments are being tested?

The 5 active trials in Bryant are testing new therapies including novel drugs, biologics, and treatment approaches for atopic dermatitis.

Data updated March 2, 2026 from ClinicalTrials.gov